Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives

Monoclonal antibodies have been the most successful therapeutics ever brought to cancer treatment by immune technologies. The use of monoclonal antibodies in B-cell Non-Hodgkin's lymphomas (NHL) represents the greatest example of these advances, as the introduction of the anti-CD20 antibody rit...

Descripción completa

Detalles Bibliográficos
Autores principales: Motta, Giulia, Cea, Michele, Moran, Eva, Carbone, Federico, Augusti, Valeria, Patrone, Franco, Nencioni, Alessio
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061293/
https://www.ncbi.nlm.nih.gov/pubmed/21437222
http://dx.doi.org/10.1155/2010/428253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061293/
https://www.ncbi.nlm.nih.gov/pubmed/21437222
http://dx.doi.org/10.1155/2010/428253

Ejemplares similares